- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/00 - Drugs for disorders of the nervous system
Patent holdings for IPC class A61P 25/00
Total number of patents in this class: 18544
10-year publication summary
|
498
|
760
|
940
|
992
|
1072
|
1189
|
1312
|
1245
|
1066
|
411
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| F. Hoffmann-La Roche AG | 7828 |
259 |
| The Regents of the University of California | 20506 |
197 |
| Takeda Pharmaceutical Company Limited | 2719 |
169 |
| Janssen Pharmaceutica N.V. | 3235 |
160 |
| Hoffmann-La Roche Inc. | 3679 |
142 |
| Centre National de La Recherche Scientifique | 10870 |
95 |
| H. Lundbeck A/S | 1242 |
94 |
| Glaxo Group Limited | 4315 |
86 |
| The Johns Hopkins University | 5813 |
86 |
| Pfizer Inc. | 3362 |
81 |
| Sage Therapeutics, Inc. | 337 |
80 |
| Novartis AG | 10350 |
79 |
| Daiichi Sankyo Company, Limited | 1885 |
79 |
| sanofi-aventis | 328 |
75 |
| Boehringer Ingelheim International GmbH | 4535 |
74 |
| Neurosearch A/S | 156 |
70 |
| Osaka University | 3309 |
64 |
| Bristol-myers Squibb Company | 4809 |
62 |
| AstraZeneca AB | 2839 |
62 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3339 |
60 |
| Other owners | 16470 |